Reviving matrix for nerve reconstruction in rat model of acute and chronic complete spinal cord injury

Shimon Rochkind; Mara Almog; Zvi Nevo

doi:10.1080/01616412.2022.2112380

Reviving matrix for nerve reconstruction in rat model of acute and chronic complete spinal cord injury

Shimon Rochkind, Mara Almog, Zvi Nevo

Research output: Contribution to journal › Article › peer-review

Abstract

This study aimed to investigate the innovative antigliotic guiding regenerative gel (AGRG) as reviving matrix for reconnection of spinal cord defect in rat models of complete acute and chronic spinal cord injury (SCI). In acute SCI, a 2 mm segment of the spinal cord (SC) was removed at Th7-Th8. Then AGRG was injected to the gap or left untreated. In chronic SCI, a 1 mm segment of the spinal cord (SC) was removed at Th7-Th8. One month later, the injured area was cleaned from connective and scar tissue, creating a gap of 2–3 mm. Then, AGRG was injected to the gap or left untreated. Functional, electrophysiological, histological and immunohistochemical assessments were performed. In acute SCI, at week 24, 75% of AGRG group showed a somatosensory evoked potential (SEP) signal. Appearance of myelin basic protein (MBP) was observed in the injured area in the AGRG group (p < 0.1), compared to the untreated group. In chronic SCI, 24 weeks after 2^nd surgery, appearance of MBP, indicating presence of myelinated axons, was observed in AGRG group, compared to the untreated group (p < 0.01). These preliminary results suggest that AGRG can serve as a vital bridging station inducing regeneration of injured SC in acute and chronic cases of paraplegia.

Original language	English
Pages (from-to)	1132-1141
Number of pages	10
Journal	Neurological Research
Volume	44
Issue number	12
DOIs	https://doi.org/10.1080/01616412.2022.2112380
State	Published - 2022
Externally published	Yes

Bibliographical note

Funding Information:
This research was funded by Baxter International Inc. We wish to express our sincere appreciation to Baxter International Inc. for the support and supervision, to Sigal Meilin, PhD and MD Biosciences, Preclinical Contract Research Organization for the supervision of the study and summary of the results, and to Emmanuel Loeb, PhD and Patho-Logica for the histological analysis.

Publisher Copyright:
© 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

Keywords

Acute and chronic spinal cord injury
antigliotic guiding regenerative gel (AGRG)
spinal cord recovery

Access to Document

10.1080/01616412.2022.2112380

Cite this

@article{714e348eb6574fda82b16f0044cb0939,

title = "Reviving matrix for nerve reconstruction in rat model of acute and chronic complete spinal cord injury",

abstract = "This study aimed to investigate the innovative antigliotic guiding regenerative gel (AGRG) as reviving matrix for reconnection of spinal cord defect in rat models of complete acute and chronic spinal cord injury (SCI). In acute SCI, a 2 mm segment of the spinal cord (SC) was removed at Th7-Th8. Then AGRG was injected to the gap or left untreated. In chronic SCI, a 1 mm segment of the spinal cord (SC) was removed at Th7-Th8. One month later, the injured area was cleaned from connective and scar tissue, creating a gap of 2–3 mm. Then, AGRG was injected to the gap or left untreated. Functional, electrophysiological, histological and immunohistochemical assessments were performed. In acute SCI, at week 24, 75% of AGRG group showed a somatosensory evoked potential (SEP) signal. Appearance of myelin basic protein (MBP) was observed in the injured area in the AGRG group (p < 0.1), compared to the untreated group. In chronic SCI, 24 weeks after 2nd surgery, appearance of MBP, indicating presence of myelinated axons, was observed in AGRG group, compared to the untreated group (p < 0.01). These preliminary results suggest that AGRG can serve as a vital bridging station inducing regeneration of injured SC in acute and chronic cases of paraplegia.",

keywords = "Acute and chronic spinal cord injury, antigliotic guiding regenerative gel (AGRG), spinal cord recovery",

author = "Shimon Rochkind and Mara Almog and Zvi Nevo",

note = "Publisher Copyright: {\textcopyright} 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.",

year = "2022",

doi = "10.1080/01616412.2022.2112380",

language = "אנגלית",

volume = "44",

pages = "1132--1141",

journal = "Neurological Research",

issn = "0161-6412",

publisher = "Maney Publishing",

number = "12",

}

TY - JOUR

T1 - Reviving matrix for nerve reconstruction in rat model of acute and chronic complete spinal cord injury

AU - Rochkind, Shimon

AU - Almog, Mara

AU - Nevo, Zvi

PY - 2022

Y1 - 2022

N2 - This study aimed to investigate the innovative antigliotic guiding regenerative gel (AGRG) as reviving matrix for reconnection of spinal cord defect in rat models of complete acute and chronic spinal cord injury (SCI). In acute SCI, a 2 mm segment of the spinal cord (SC) was removed at Th7-Th8. Then AGRG was injected to the gap or left untreated. In chronic SCI, a 1 mm segment of the spinal cord (SC) was removed at Th7-Th8. One month later, the injured area was cleaned from connective and scar tissue, creating a gap of 2–3 mm. Then, AGRG was injected to the gap or left untreated. Functional, electrophysiological, histological and immunohistochemical assessments were performed. In acute SCI, at week 24, 75% of AGRG group showed a somatosensory evoked potential (SEP) signal. Appearance of myelin basic protein (MBP) was observed in the injured area in the AGRG group (p < 0.1), compared to the untreated group. In chronic SCI, 24 weeks after 2nd surgery, appearance of MBP, indicating presence of myelinated axons, was observed in AGRG group, compared to the untreated group (p < 0.01). These preliminary results suggest that AGRG can serve as a vital bridging station inducing regeneration of injured SC in acute and chronic cases of paraplegia.

AB - This study aimed to investigate the innovative antigliotic guiding regenerative gel (AGRG) as reviving matrix for reconnection of spinal cord defect in rat models of complete acute and chronic spinal cord injury (SCI). In acute SCI, a 2 mm segment of the spinal cord (SC) was removed at Th7-Th8. Then AGRG was injected to the gap or left untreated. In chronic SCI, a 1 mm segment of the spinal cord (SC) was removed at Th7-Th8. One month later, the injured area was cleaned from connective and scar tissue, creating a gap of 2–3 mm. Then, AGRG was injected to the gap or left untreated. Functional, electrophysiological, histological and immunohistochemical assessments were performed. In acute SCI, at week 24, 75% of AGRG group showed a somatosensory evoked potential (SEP) signal. Appearance of myelin basic protein (MBP) was observed in the injured area in the AGRG group (p < 0.1), compared to the untreated group. In chronic SCI, 24 weeks after 2nd surgery, appearance of MBP, indicating presence of myelinated axons, was observed in AGRG group, compared to the untreated group (p < 0.01). These preliminary results suggest that AGRG can serve as a vital bridging station inducing regeneration of injured SC in acute and chronic cases of paraplegia.

KW - Acute and chronic spinal cord injury

KW - antigliotic guiding regenerative gel (AGRG)

KW - spinal cord recovery

UR - http://www.scopus.com/inward/record.url?scp=85136519495&partnerID=8YFLogxK

U2 - 10.1080/01616412.2022.2112380

DO - 10.1080/01616412.2022.2112380

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 35998212

AN - SCOPUS:85136519495

SN - 0161-6412

VL - 44

SP - 1132

EP - 1141

JO - Neurological Research

JF - Neurological Research

IS - 12

ER -

Reviving matrix for nerve reconstruction in rat model of acute and chronic complete spinal cord injury

Abstract

Bibliographical note

Keywords

Access to Document

Other files and links

Fingerprint

Cite this